This is a delivery order contract awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) for the delivery of Eliquis 5 mg tablets. The contract, valued at $10,949.56, has a firm fixed price and an ultimate completion date of December 4, 2024. Dakota Drug, Inc. is the prime contractor, and there are no major subcontractors mentioned.
The contract is part of the DLA Troop Support Medical's ECAT Generation V Program, which is an Indefinite Delivery Contract (IDC) valued at $999,999,999.00. This IDC allows Dakota Drug, Inc. to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The contract does not have a set-aside designation.
Generated 3/4/25, 11:21 AM